Yoseph Samodra: Hematopoiesis and the Nutrients Behind Blood Formation
Yoseph Samodra, Postdoctoral Researcher at Academia Sinica, shared a post on LinkedIn:
“Blood production is a continuous biological process that must respond to oxygen demands, tissue repair, immune activity, bleeding, infection, pregnancy, and many other physiological changes.
Hematopoiesis is the formation of blood cells, including red blood cells, white blood cells, and platelets.
Erythropoiesis is the specific process of producing new red blood cells.
Because mature red blood cells have an average lifespan of approximately 100 to 120 days, the body must replace about 0.8 to 1 percent of them every day.
This process depends on healthy bone marrow, appropriate hormonal signals, and adequate supplies of iron, vitamins, protein, and other nutrients.
When any part of this system is disrupted, anemia or another hematologic disorder may develop.
Hematopoiesis, Erythropoiesis, and Anemia
Hematopoiesis begins with hematopoietic stem cells in the bone marrow.
These cells can develop into different blood cell lineages.
Their production is regulated by growth factors, inflammatory signals, and tissue demands.
Erythropoiesis is strongly regulated by erythropoietin, a hormone produced primarily by the kidneys in response to reduced oxygen availability.
Erythropoietin stimulates the bone marrow to increase red blood cell production.
The newly formed cells gradually accumulate hemoglobin, lose their nucleus, and enter the bloodstream as mature red blood cells.
Hemoglobin enables red blood cells to transport oxygen from the lungs to tissues and carry carbon dioxide back to the lungs.
For this reason, inadequate red blood cell production or reduced hemoglobin concentration can affect nearly every organ system.
The World Health Organization identifies anemia using hemoglobin thresholds that vary according to age, sex, pregnancy status, altitude, and other factors.
Common adult thresholds are hemoglobin below 13 g/dL in men and below 12 g/dL in nonpregnant women, but clinical interpretation should always consider the relevant population and laboratory reference range.
Anemia may cause:
- Fatigue and reduced exercise tolerance.
- Pale skin or pale conjunctiva.
- Dizziness, headaches, or vertigo.
- Shortness of breath.
- Palpitations.
- Chest discomfort in more severe cases.
- Cold hands and feet.
- Poor concentration.
- Sleep disturbance.
- Irritability or changes in mood.
The severity of symptoms depends on the degree of anemia, how quickly it develops, the patient’s age, and the presence of heart, lung, kidney, or other chronic disease.
Anemia is not a single disease.
It may result from nutritional deficiency, blood loss, increased red blood cell destruction, chronic inflammation, infection, kidney disease, inherited hemoglobin disorders, or bone marrow dysfunction.
Nutritional assessment is therefore important, but it should be part of a broader clinical evaluation.
Nutrients, Iron Deficiency, and Blood Formation
Blood formation requires a coordinated supply of multiple nutrients.
Iron is necessary for hemoglobin synthesis, while folate and vitamin B12 are essential for DNA synthesis and normal cell division.
Vitamin B6 contributes to amino acid metabolism and heme production.
Other nutrients also support hematopoiesis and blood cell function:
- Protein provides amino acids for cellular structures and enzymes.
- Carbohydrates provide energy for rapidly dividing cells.
- Vitamin C supports connective tissue and improves the absorption of nonheme iron.
- Riboflavin, or vitamin B2, participates in cellular energy metabolism.
- Vitamins A, D, E, and K support immune function, cell differentiation, antioxidant defense, bone health, and coagulation.
- Copper supports iron transport and utilization through proteins such as ceruloplasmin.
- Zinc supports cell division, immune function, and tissue repair.
- Calcium, phosphorus, magnesium, and essential fatty acids contribute to cellular and skeletal processes.
Among nutritional deficiencies, iron deficiency is one of the most common worldwide and is a major cause of iron-deficiency anemia.
The process typically develops in stages.
First, iron stores decline.
At this stage, hemoglobin may remain within the reference range, but serum ferritin begins to fall.
Next, iron becomes insufficient for normal red blood cell production.
In the final stage, hemoglobin synthesis is impaired and iron-deficiency anemia develops.
Iron requirements increase during pregnancy because the body must support expansion of maternal red blood cell mass, increased blood volume, placental development, and fetal growth.
Iron deficiency during pregnancy is associated with adverse maternal and infant outcomes, including preterm birth, low birth weight, and impaired developmental outcomes.
Public health programs may recommend iron and folic acid supplementation for pregnant women or women of reproductive age, particularly in areas where anemia is common and food fortification is not sufficient.
The specific dose and schedule should follow national or clinical guidelines.
Hemoglobin is commonly used to screen for anemia, but it does not identify the cause.
Serum ferritin is generally more informative for evaluating iron stores.
However, ferritin is also an acute-phase reactant, so inflammation, infection, liver disease, or chronic illness may increase ferritin even when iron availability is poor.
For this reason, iron assessment may also include transferrin saturation, total iron-binding capacity, reticulocyte hemoglobin, inflammatory markers, and a complete blood count.
Iron Absorption and Dietary Sources
Iron is found in two main dietary forms.
Heme iron is present in animal foods and is generally more bioavailable.
Sources include red meat, liver, seafood, oysters, fish, poultry, and egg yolks.
Nonheme iron is found in plant foods and fortified products.
Sources include legumes, nuts, dried fruit, leafy vegetables, whole grains, and fortified cereals.
Vitamin C, citric acid, and some amino acids can improve the absorption of nonheme iron.
Foods containing vitamin C include citrus fruit, tomatoes, bell peppers, strawberries, and broccoli.
Absorption may be reduced by phytates, tannins, tea, coffee, cocoa, and certain dietary patterns rich in compounds that bind iron.
The timing and composition of meals can therefore influence iron absorption.
Oral iron may be prescribed as ferrous sulfate, ferrous fumarate, or ferrous gluconate.
Intravenous iron may be considered when oral treatment is ineffective, poorly tolerated, insufficiently absorbed, or unsuitable for the clinical situation.
However, iron should not be taken automatically whenever anemia is detected.
Excess iron can contribute to oxidative stress and tissue injury.
This is especially important in people with thalassemia, sickle cell disease, repeated blood transfusions, chronic liver disease, or anemia associated with inflammation.
In anemia of chronic disease, hemoglobin may be low even when serum ferritin is normal or elevated.
Inflammation can increase hepcidin, a hormone that reduces intestinal iron absorption and traps iron inside storage cells.
Giving additional iron without confirming iron deficiency may therefore provide little benefit and may increase risk.
Folate, Vitamin B12, Vitamin B6, and Copper
Folate is required for DNA synthesis and normal red blood cell maturation.
Deficiency can result in megaloblastic anemia, in which red blood cells become unusually large and develop abnormally because cell division is impaired.
Folate deficiency may also increase homocysteine levels and is particularly important during pregnancy because adequate folic acid intake reduces the risk of neural tube defects.
Food sources include leafy green vegetables, legumes, asparagus, avocado, tomatoes, citrus fruits, liver, and fortified grain products.
Folate is sensitive to oxidation and prolonged cooking, so food preparation can affect its availability.
Vitamin B12 supports DNA synthesis, red blood cell formation, cell growth, and nervous system function.
People who follow a vegan diet may need fortified foods or supplements because naturally occurring vitamin B12 is found mainly in animal-derived foods.
B12 deficiency can cause anemia and neurological problems, sometimes even before anemia becomes obvious.
Vitamin B6 supports amino acid metabolism and heme production.
Copper participates in iron transport and utilization through ceruloplasmin.
Excessive zinc supplementation can interfere with copper absorption, while very high doses of vitamin C may also affect copper status in some circumstances.
Nutrition in Specific Hematologic Conditions
Nutritional needs vary according to the underlying cause of anemia or blood disorder.
A diet that is appropriate for iron-deficiency anemia may be inappropriate for a person with iron overload.
In anemia related to prematurity, attention may be given to iron, copper, calcium, phosphorus, magnesium, vitamin D, vitamin E, vitamin B12, and folate.
The needs of preterm infants should be managed using pediatric and neonatal protocols because both deficiency and excessive supplementation can be harmful.
In hemolytic anemia, red blood cells are destroyed more rapidly than normal.
Adequate folate may be important because the bone marrow is working harder to produce replacement cells.
Vitamin E and zinc status may also require attention, but supplementation should be guided by clinical assessment.
People with sickle cell disease may need adequate energy, protein, hydration, folate, and a varied intake of vitamins and minerals.
Nutritional care should be individualized according to growth, kidney function, inflammation, medication use, and transfusion history.
Frequent transfusions can lead to iron overload and may require monitoring and chelation therapy.
In thalassemia, iron overload can result from repeated transfusions or increased intestinal iron absorption.
People with thalassemia should not take iron supplements unless iron deficiency has been confirmed.
Dietary iron and vitamin C intake should be discussed with the treating clinician rather than restricted or increased without guidance.
Anemia associated with chronic kidney disease may involve reduced erythropoietin production, inflammation, and impaired iron availability.
Iron and B-vitamin treatment may be appropriate in some patients, but dietary recommendations must also account for kidney function, potassium, phosphorus, fluid status, and dialysis requirements.
In malaria-endemic settings, iron supplementation should be considered carefully, especially when infection is active or when iron status is unknown.
The underlying infection and the patient’s iron stores should be evaluated before routine supplementation.
People with bleeding disorders may require adequate protein, iron, folate, vitamin B12, copper, and vitamin K.
High-dose vitamin E supplements should be avoided unless specifically recommended because vitamin E can affect platelet function and bleeding risk.
Patients with polycythemia vera require individualized medical and nutritional monitoring because the condition involves excessive blood cell production rather than inadequate production.
Iron supplementation should not be started casually because iron deficiency may sometimes limit red blood cell production, while supplementation may increase erythrocytosis.
In thrombocytopenia, nutrition should support overall health and treatment tolerance, but no single food reliably corrects a low platelet count.
Folate, vitamin B12, vitamin K, protein, and overall dietary adequacy may be reviewed when clinically relevant.
After splenectomy, adequate energy, protein, zinc, vitamin A, and vitamin C can support recovery and immune function.
However, vaccination, infection prevention, and appropriate medical follow-up are also essential.
Conclusion
Hematopoiesis is a continuous process that depends on the interaction between bone marrow, kidneys, hormones, nutrients, and the immune system.
Iron is essential for hemoglobin, but it is only one part of the nutritional foundation of blood formation.
Folate, vitamin B12, vitamin B6, copper, protein, and other micronutrients are also necessary for red blood cell production, maturation, membrane stability, and immune function.
The most appropriate nutritional strategy depends on the cause of anemia.
Iron deficiency requires iron replacement, but anemia caused by inflammation, kidney disease, hemoglobin disorders, infection, or blood loss requires a different approach.
Laboratory testing, medical history, dietary assessment, and clinical examination should guide supplementation.
The goal is not simply to increase a single nutrient, but to correct the underlying problem while avoiding the risks of unnecessary treatment.”

Stay updated with Hemostasis Today.
-
Sep 7, 2026, 09:31Felix Scholkmann: Serotonin and the Formation of Microvascular Fibrin
-
Sep 7, 2026, 09:22Aryan Mishra: β-Thalassemia Analyzer: HPLC for Hemoglobinopathy Screening
-
Sep 7, 2026, 09:04Daniel Pereira Monteiro: Haemopaedia Case of the Week – Hemoglobinopathy Diagnosis and Confirmatory Testing
-
Sep 7, 2026, 08:51Judith de Vos: The Immune Composition of Thrombi in Ischemic Stroke
-
Sep 7, 2026, 08:50Maria Cherska: Lipid Metabolism and Immune Remodeling in Metastatic Colorectal Cancer
-
Sep 7, 2026, 08:28Deanna Joseph: Exploring Factor XIII Deficiency Through Summer Research
-
Sep 7, 2026, 08:17Nasim Hosseini: Women’s Blood Donation and the Social Determinants of Health
-
Sep 7, 2026, 08:12David McIntosh: The Global Plasma Supply Debate
-
Sep 7, 2026, 08:03Julio Avella: Advancing IDA Care Through Scientific Education and Collaboration